Neogen ROE 2006-2019 | NEOG

Current and historical return on equity (ROE) values for Neogen (NEOG) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Neogen ROE for the three months ending February 28, 2019 was 10.48%.
Neogen ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-02-28 $0.06B $0.62B 10.49%
2018-11-30 $0.07B $0.60B 11.55%
2018-08-31 $0.07B $0.58B 12.15%
2018-05-31 $0.06B $0.56B 12.13%
2018-02-28 $0.06B $0.54B 11.47%
2017-11-30 $0.05B $0.52B 10.56%
2017-08-31 $0.05B $0.49B 9.75%
2017-05-31 $0.04B $0.47B 9.68%
2017-02-28 $0.04B $0.45B 9.60%
2016-11-30 $0.04B $0.44B 9.49%
2016-08-31 $0.04B $0.42B 9.33%
2016-05-31 $0.04B $0.40B 9.38%
2016-02-29 $0.04B $0.39B 9.44%
2015-11-30 $0.03B $0.38B 9.50%
2015-08-31 $0.03B $0.37B 9.56%
2015-05-31 $0.03B $0.35B 9.90%
2015-02-28 $0.03B $0.34B 9.93%
2014-11-30 $0.03B $0.33B 10.30%
2014-08-31 $0.03B $0.32B 10.02%
2014-05-31 $0.03B $0.31B 10.09%
2014-02-28 $0.03B $0.29B 10.16%
2013-11-30 $0.03B $0.28B 10.60%
2013-08-31 $0.03B $0.27B 11.45%
2013-05-31 $0.03B $0.26B 11.53%
2013-02-28 $0.03B $0.25B 11.59%
2012-11-30 $0.03B $0.24B 11.16%
2012-08-31 $0.02B $0.23B 10.69%
2012-05-31 $0.02B $0.22B 10.62%
2012-02-29 $0.02B $0.21B 11.01%
2011-11-30 $0.02B $0.20B 11.47%
2011-08-31 $0.02B $0.20B 12.50%
2011-05-31 $0.02B $0.19B 13.14%
2011-02-28 $0.02B $0.18B 13.25%
2010-11-30 $0.02B $0.17B 13.29%
2010-08-31 $0.02B $0.16B 13.29%
2010-05-31 $0.02B $0.15B 12.50%
2010-02-28 $0.02B $0.15B 11.59%
2009-11-30 $0.02B $0.14B 11.30%
2009-08-31 $0.01B $0.14B 10.98%
2009-05-31 $0.01B $0.13B 11.41%
2009-02-28 $0.01B $0.13B 11.84%
2008-11-30 $0.01B $0.12B 12.36%
2008-08-31 $0.01B $0.12B 11.98%
2008-05-31 $0.01B $0.11B 11.59%
2008-02-29 $0.01B $0.11B 11.14%
2007-11-30 $0.01B $0.10B 10.58%
2007-08-31 $0.01B $0.10B 9.97%
2007-05-31 $0.01B $0.09B 9.20%
2007-02-28 $0.01B $0.09B 9.97%
2006-11-30 $0.01B $0.09B 9.49%
2006-08-31 $0.01B $0.08B 10.37%
2006-05-31 $0.01B $0.07B 11.48%
2006-02-28 $0.01B $0.06B 8.55%
2005-11-30 $0.01B $0.06B 8.89%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.935B $0.402B
Neogen Corporation develops, manufactures and markets a diverse line of products dedicated to food and animal safety. The Company's Lansing, Mich.-based Food Safety Division develops and markets dehydrated culture media, and rapid diagnostic test kits to detect foodborne bacteria, spoilage organisms, mycotoxins, food allergens, genetic modifications, drug residues, plant diseases, and sanitation concerns. Neogen's is the leading global provider of DNA testing for animal agribusiness and veterinary medicine. Neogen understands that its customers face serious consequences if their products are contaminated with any of a number of well-established or emerging threats, including dangerous bacteria, natural toxins, veterinary drug residues, unlabeled food allergens, rodent filth, sanitation concerns, broken veterinary needles or other contaminants.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $130.875B 25.52
Medtronic (MDT) Ireland $112.858B 16.50
Stryker (SYK) United States $67.965B 24.92
Boston Scientific (BSX) United States $48.570B 23.60
Baxter (BAX) United States $38.462B 24.67
Zimmer Biomet Holdings (ZBH) United States $24.795B 15.86
Canopy Growth (CGC) Canada $16.605B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.541B 0.00
ResMed (RMD) United States $14.331B 27.18
Aurora Cannabis (ACB) Canada $9.351B 65.93
Bio-Rad Laboratories (BIO) United States $8.746B 50.17
Perrigo (PRGO) Ireland $6.654B 10.79
Hill-Rom Holdings (HRC) United States $6.265B 19.38
Insulet (PODD) United States $4.918B 1648.60
GW Pharmaceuticals (GWPH) United Kingdom $4.886B 0.00
ICU Medical (ICUI) United States $4.648B 28.79
Haemonetics (HAE) United States $4.248B 37.69
Hutchison China MediTech (HCM) China $4.058B 0.00
Agios Pharmaceuticals (AGIO) United States $3.323B 0.00
NuVasive (NUVA) United States $2.870B 24.93
Quidel (QDEL) United States $2.395B 21.43
National Vision Holdings (EYE) United States $2.233B 43.92
Aphria (APHA) $1.970B 0.00
HEXO (HEXO) $1.493B 0.00
Phibro Animal Health (PAHC) United States $1.350B 19.40
Cardiovascular Systems (CSII) United States $1.210B 868.75
VAREX IMAGING (VREX) United States $1.209B 23.67
AtriCure (ATRC) United States $1.055B 0.00
Lantheus Holdings (LNTH) United States $0.930B 25.13
Omeros (OMER) United States $0.916B 0.00
PetIQ (PETQ) United States $0.851B 24.35
Cerus (CERS) United States $0.808B 0.00
MacroGenics (MGNX) United States $0.796B 0.00
NanoString Technologies (NSTG) United States $0.744B 0.00
TG Therapeutics (TGTX) United States $0.699B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.676B 23.00
Evolus (EOLS) United States $0.665B 0.00
OraSure Technologies (OSUR) United States $0.585B 25.46
Surmodics (SRDX) United States $0.569B 82.72
LeMaitre Vascular (LMAT) United States $0.539B 25.61
Meridian Bioscience (VIVO) United States $0.534B 15.90
Quanterix (QTRX) United States $0.492B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.330B 0.00
Insys Therapeutics (INSY) United States $0.322B 0.00
Utah Medical Products (UTMD) United States $0.321B 20.90
BioLife Solutions (BLFS) United States $0.303B 125.08
Vapotherm (VAPO) United States $0.281B 0.00
Rockwell Medical (RMTI) United States $0.263B 0.00
Cytosorbents (CTSO) United States $0.227B 0.00
Owens & Minor (OMI) United States $0.214B 2.93
Zynex (ZYXI) United States $0.170B 18.21
Chimerix (CMRX) United States $0.136B 0.00
Bovie Medical (APYX) United States $0.132B 0.00
Fonar (FONR) United States $0.123B 6.59
Chembio Diagnostics (CEMI) United States $0.120B 0.00
Surface Oncology (SURF) United States $0.111B 0.00
Female Health (VERU) United States $0.090B 0.00
United-Guardian (UG) United States $0.089B 20.42
InfuSystems Holdings (INFU) United States $0.088B 0.00
Neurotrope (NTRP) United States $0.078B 0.00
Trinity Biotech (TRIB) Ireland $0.069B 20.64
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
GUARDION HEALTH (GHSI) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Senestech (SNES) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.030B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.023B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.007B 13.00